(Q36319610)

13 August 2017

1 reference

title

Long-term outcomes in juvenile dermatomyositis: how did we get here and where are we going? (English)

1 reference

13 August 2017

0 references

Adam Huber

1

1 reference

13 August 2017

Brian M Feldman

series ordinal

2

1 reference

13 August 2017

publication date

1 December 2005

1 reference

Current Rheumatology Reports

13 August 2017

published in

1 reference

13 August 2017

volume

7

1 reference

13 August 2017

issue

6

1 reference

13 August 2017

page(s)

441-446

1 reference

https://scigraph.springernature.com/pub.10.1007/s11926-005-0048-1

13 August 2017

exact match

0 references

cites work

Dermatomyositis; a review of nineteen cases in adolescents and children

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11926-005-0048-1

Aerobic exercise capacity in patients with juvenile dermatomyositis

21 January 2018

1 reference

12 December 2020

Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes

1 reference

12 December 2020

Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies

1 reference

12 December 2020

Juvenile dermatomyositis. Pathophysiology and disease expression

1 reference

12 December 2020

Juvenile dermatomyositis: a clinical and immunologic study

1 reference

12 December 2020

Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyos

1 reference

12 December 2020

Treatment of dermatomyositis with intravenous gammaglobulin

1 reference

12 December 2020

Prognosis in juvenile dermatopolymyositis: a cooperative retrospective study of 70 cases

1 reference

12 December 2020

Dermatomyositis in childhood; a summary of 40 cases

1 reference

12 December 2020

Juvenile dermatomyositis: clinical profile and disease course in 25 patients

1 reference

12 December 2020

Cyclosporin a therapy in refractory juvenile dermatomyositis. Experience and longterm followup of 6 cases

1 reference

12 December 2020

The incidence of juvenile dermatomyositis: results from a nation-wide study

1 reference

12 December 2020

Childhood polymyositis. A follow-up study with special reference to treatment with corticosteroids

1 reference

12 December 2020

Prognosis in childhood dermatomyositis

1 reference

12 December 2020

Validation of the Childhood Health Assessment Questionnaire in the juvenile idiopathic myopathies. Juvenile Dermatomyositis Disease Activity Collaborative Study Group

1 reference

12 December 2020

Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Juvenile Dermatomyositis Disease Activity Collaborative Study Group

1 reference

12 December 2020

Late progression in dermatomyositis in childhood

1 reference

12 December 2020

Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis

1 reference

12 December 2020

Dermatomyositis; report of 26 cases in children with a discussion of endocrine therapy in 13

1 reference

12 December 2020

Decreased aerobic capacity in children with juvenile dermatomyositis

1 reference

12 December 2020

Persistance of activity in dermatomyositis of childhood

1 reference

12 December 2020

Childhood dermatomyositis. Clinical course and long-term follow-up

1 reference

12 December 2020

Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis

1 reference

12 December 2020

The arthritis of inflammatory childhood myositis syndromes

1 reference

12 December 2020

Measuring disability in juvenile dermatomyositis: validity of the childhood health assessment questionnaire.

1 reference

12 December 2020

Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies

1 reference

12 December 2020

Childhood dermatomyositis: factors predicting functional outcome and development of dystrophic calcification

1 reference

12 December 2020

Dermatomyositis in early childhood

1 reference

12 December 2020

Dermatomyositis in the pediatric patient

1 reference

12 December 2020

Juvenile dermatomyositis: medical, social and economic status in adulthood.

1 reference

12 December 2020

Course of treated juvenile dermatomyositis

1 reference

12 December 2020

Juvenile dermatomyositis: a retrospective review of a 30-year experience

1 reference

12 December 2020

Dermatomyositis in childhood. Review of eight cases

1 reference

12 December 2020

Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence

1 reference

12 December 2020

Lipodystrophy in patients with juvenile dermatomyositis--evaluation of clinical and metabolic abnormalities.

1 reference

12 December 2020

Rituximab in the treatment of dermatomyositis: an open-label pilot study

1 reference

12 December 2020

Treatment of dermatomyositis in childhood

1 reference

12 December 2020

US incidence of juvenile dermatomyositis, 1995-1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry

1 reference

12 December 2020

Drug treatment of juvenile dermatomyositis

1 reference

12 December 2020

Drug therapy in juvenile dermatomyositis: follow-up study

1 reference

12 December 2020

Normal scores for nine maneuvers of the Childhood Myositis Assessment Scale

1 reference

12 December 2020

Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis

1 reference

12 December 2020

1 reference

12 December 2020

Juvenile dermatomyositis and polymyositis: a follow-up study of long-term sequelae

1 reference

12 December 2020

10.1007/S11926-005-0048-1

Identifiers

DOI

1 reference

13 August 2017

1 reference